Lupin Limited has achieved a remarkable World Record for conducting the Largest Multi-Clinic Observational Study on Diabetes. The landmark study involved 100,241 patients across 2,612 clinics throughout India, making it one of the most extensive real-world diabetes studies ever undertaken in the country.
The large-scale observational study focused on patients receiving Dapagliflozin therapy, collecting comprehensive real-world data on patient demographics, duration of diabetes, laboratory parameters, treatment patterns, and clinical outcomes. The initiative aimed to enhance clinical understanding of diabetes management and generate valuable evidence to support informed healthcare decisions.
By engaging thousands of healthcare professionals and over one lakh patients nationwide, the study underscores Lupin Limited’s commitment to advancing medical research, improving patient care, and contributing to evidence-based diabetes treatment practices. The findings are expected to provide meaningful insights into the effectiveness of diabetes therapies in routine clinical settings.
